Alkaya Murat Alp, Saraçoğlu Kemal Tolga, Pehlivan Gökhan, Eti Zeynep, Göğüş Fevzi Yılmaz
Department of Anaesthesiology and Reanimation, Marmara University Faculty of Medicine, İstanbul, Turkey.
Turk J Anaesthesiol Reanim. 2014 Apr;42(2):86-90. doi: 10.5152/TJAR.2013.57. Epub 2013 Aug 29.
The aim of this study was to evaluate the effects of esmolol infusion on the prevention of haemodynamic responses to tracheal extubation in patients undergoing elective craniotomy.
With approval from the Medical School Ethics Committee at Marmara University and the patients' written consent, 30 patients between 20-65 years of age undergoing elective craniotomy were randomly placed in either the Group Esmolol (n=15) or the Group Control (n=15). Anaesthesia was induced with 5-7 mg kg(-1) thiopental sodium, 1 μg kg(-1) remifentanil, and 0.1 mg kg(-1) vecuronium bromide iv, and was maintained with 1 MAC sevoflurane in oxygen-air mixture (50:50) and 0.25 μg kg(-1) min(-1) remifentanil infusion. At the end of the operation, patients inhaled 100% oxygen after the discontinuation of the anaesthetic agents. For Group Esmolol, 5 min before extubation 2 mg kg(-1) esmolol in 50 mL was infused over 10 min (0.2 μg kg(-1) min(-1)), while for Group Control, 50 mL saline was infused over 10 min. The quality of extubation was evaluated with a 5 point scale, recording heat rate, systolic, diastolic, and mean arterial pressures before infusion, 1 min after infusion, during extubation, and at 1, 3, 5, and 10 min after extubation.
In the esmolol group, systolic, diastolic, and mean arterial pressures, as well as heart rate, decreased significantly after esmolol infusion and were significantly lower than in the control group after extubation (p<0.05). The ratio of patients with an extubation score of one was significantly higher in the esmolol group than in the control group (p<0.05).
We concluded that 2 mg kg(-1) esmolol infusion before extubation can prevent hypertension and tachycardia caused by extubation in patients undergoing elective craniotomy.
本研究旨在评估艾司洛尔输注对择期开颅手术患者预防气管拔管时血流动力学反应的效果。
经马尔马拉大学医学院伦理委员会批准并获得患者书面同意后,将30例年龄在20 - 65岁之间接受择期开颅手术的患者随机分为艾司洛尔组(n = 15)和对照组(n = 15)。静脉注射5 - 7 mg·kg⁻¹硫喷妥钠、1 μg·kg⁻¹瑞芬太尼和0.1 mg·kg⁻¹维库溴铵诱导麻醉,并用1 MAC七氟醚在氧气 - 空气混合气体(50:50)中及0.25 μg·kg⁻¹·min⁻¹瑞芬太尼输注维持麻醉。手术结束时,停用麻醉剂后患者吸入100%氧气。对于艾司洛尔组,在拔管前5分钟,将50 mL中含2 mg·kg⁻¹艾司洛尔的溶液在10分钟内输注完毕(0.2 μg·kg⁻¹·min⁻¹),而对照组在10分钟内输注50 mL生理盐水。用5分制评估拔管质量,记录输注前、输注后1分钟、拔管期间以及拔管后1、3、5和10分钟时的心率、收缩压、舒张压和平均动脉压。
艾司洛尔组在输注艾司洛尔后,收缩压、舒张压、平均动脉压以及心率均显著下降,且拔管后明显低于对照组(p < 0.05)。艾司洛尔组拔管评分为1分的患者比例显著高于对照组(p < 0.05)。
我们得出结论,拔管前输注2 mg·kg⁻¹艾司洛尔可预防择期开颅手术患者拔管引起的高血压和心动过速。